International Dementia Conference Series (IDCS)


The International Dementia Conference Series promotes exchanges between students/trainees and established scientists in the field of Dementia.

It is a space for scientists from around the world and is aimed at facilitating collaborative endeavors through the discussion of the works presented. These presentations constitute the frontiers of knowledge in Dementia research and promote the cultivation of new ideas and directions to pursue.

This series also aims to embody the translational nature of research by bringing together specialists in in vitro studies focused on understanding individual biological constituents of disease, in vivo studies whereby these individual constituents are studied in the context of model organisms of disease, and in clinical studies where we find emergence of these constituents in humans affected by disease.

This level of communication across the hierarchy of research environments will be a crucial component towards finding solutions to these complex and devastating illnesses.


Official Website coming soon!


Past Events

2020-06-05

Marcelo Zimmer

Hypothalamic Agrp neurons mediate neonatal behaviours in mice

Postdoctoral Associate, Yale School of Medicine, new Haven, Connecticut

2020-07-08

Igor Fontana

Development of PET radiotracer for imaging glutamate transporters in the brain

Ph.D. Candidate Biochemistry, Zimmer Lab,
Universidade Federal do Rio Grande do Sul
Porto Alegre, Brazil

2020-07-15

Peter Kang

Synergistic underpinning of amyloid and neuroinflammation underlies tau propagation in Alzheimer’s disease

Ph.D. Candidate, Rosa-Neto Lab, McGill University,
Quebec, Canada

2020-07-22

Guihlerme Povala

Soluble amyloid-beta isoforms predict
downstream Alzheimer’s disease pathology

Ph.D. Candidate Biochemistry, Zimmer Lab,
Universidade Federal do Rio Grande do Sul
Porto Alegre, Brazil

2020-08-19

Vasavan Nair

The Alzheimer’s Conundrum – Urgent need for
a paradigm shift

Director, Human Psychopharmacology Trials,
Douglas Research Centre
Medical Director, Moe Levin Memory Clinic,
Douglas Mental Health University Institute
Full Professor, Department of Psychiatry, McGill
University

2020-08-26

Marco Antonio Bastiani

Transcriptomic evaluation of hAB-KI mouse
model and LOAD

Postdoc Biochemistry, Zimmer Lab, Universidade
Federal do Rio Grande do Sul

2020-09-02

Pamela Lukasewicz

The endocannabinoid system as potential
target for novel biomarkers in Alzheimer’s
disease

Postdoc Biochemistry, Zimmer Lab, Universidade
Federal do Rio Grande do Sul

2020-09-09

Bruna Bellaver

Astrocyte biomarkers in Alzheimer’s disease: a
systematic review and meta-analysis

Postdoc Biochemistry, Zimmer Lab, Universidade
Federal do Rio Grande do Sul

2020-10-28

Diego Bohorquez

A gut choice

Associate Professor in Medicine,
Assistant Research Professor in Neurobiology,
Associate Professor in Pathology,
Faculty Network Member of the Duke Institute for
Brain Sciences

2020-11-04

Andreia Rocha

Astrocyte glutamate uptake impacts [18F]FDGPET signal

Ph.D. Candidate Biochemistry, Zimmer Lab,
Universidade Federal do Rio Grande do Sul
Porto Alegre, Brazil

2020-11-11

Carolina Soares

Microglial metabolism in AD

Ph.D. Candidate Biochemistry, Zimmer Lab,
Universidade Federal do Rio Grande do Sul
Porto Alegre, Brazil

2020-11-25

Peter Kunach

Transmission of tauopathy strains is
independent of their isoform composition

M.Sc. Candidate, Rosa-Neto Lab, McGill University,
Quebec, Canada

2020-12-02

Cecile Tissot

Discrepancy between plasm ptau-181 and tauPET statuses

Ph.D. Candidate, Rosa-Neto Lab, McGill University,
Quebec, Canada

2021-03-03

Pedro Rosa Neto

Assessing AD stages using tau-PET

Director, Translational Neuroimaging Laboratory,
Douglas Research Centre
Group Leader, Aging, Cognition, and Alzheimer’s
Disease
Director, McGill University Research Centre for
Studies in Aging, Douglas Research Centre
Associate Professor, Department of Neurology and
Neurosurgery, McGill University
Associate Professor, Department of Psychiatry,
McGill University
Clinical Research Scholar, Fonds de recherche du
Québec – Santé (FRQS), Senior

2021-03-31

Kelvin Luk

Insights from models of alpha-synuclein spread –
seeding things from different perspectives

Research Associate Professor of Pathology
and Laboratory Medicine

2021-04-07

Per Borghammer

The alpha-synuclein origin and connectome (SOC)
model in Parkinson’s disease pathogenesis – explaining
non-motor phenotypes, motor asymmetry and
cognitive decline

Chief Consultant and Associate Professor
at the Department of Nuclear Medicine &
PET Centre, Aarhus University Hospital,
Denmark.

2021-04-21

Rodger Liddle

The gut connectome in Parkinson’s disease

2021-05-05

Luc Pellerin

Role of monocarboxylate transporters in neuronastrocyte metabolic interactions to sustain behavioral
performance

Upcoming Events

2021-05-26

Carole Escartin

Exploring the complex roles of reactive astrocytes in
neurodegenerative diseases

2021-06-02

Eduardo Zimmer

Astrocytes in FDG PET signal

2021-06-16

Agneta Nordberg

Reactive astrogliosis at different stages of Alzheimer´s
disease –relationship with other pathology biomarkers
and clinical implications

2021-07-14

Shane Liddlelow

What do reactive Astrocytes really do?